Anti Cancer Drug 114977-28-5 Docetaxel Powder

Short Description:

Docetaxel is an important drug material,which is widely used in pharmaceutical industry.


Product Detail

Product Tags

Product Informations

Name:Docetaxel

CAS number:114977-28-5

Chemical formula:C45H57NO14

Specifications:99%

Color:white powder

Source:Semi-synthesized with 10-DAB

Type:APIs

Characteristics and uses

Docetaxel is a potent non-selective beta-receptor blocker that is primarily used to treat cardiovascular disease.It reduces the stimulation of the sympathetic nervous system by blocking beta receptors,thereby reducing heart rate,reducing blood pressure,and reducing cardiac load,and has significant therapeutic effect on patients with heart disease.

Quality standards

The quality standards of docetaxel raw materials meet the requirements of the International Pharmacopoeia and comply with the relevant standards of the pharmaceutical industry.The high purity,impurity free docetaxel raw material ensures the quality stability and efficacy of the drug.

Production process

The production process of Docetaxel raw materials is carefully designed and developed using an optimized synthesis route.This process can efficiently synthesize docetaxel with high yield and purity.

Security and stability

Docetaxel raw materials showed good safety and stability in pharmaceutical preparations.Strict quality control and stability testing ensure the long-term preservation and stability of Docetaxel raw materials during use.

Application field

Docetaxel ingredients are widely used in the pharmaceutical industry,especially in the field of cardiovascular disease.

Our Services

1.Products:Provide high-quality,high-purity plant extracts,pharmaceutical raw materials,and pharmaceutical intermediates.

2.Technical services:Customized extracts with special specifications according to customer requirements.

Hande factory

Be the best supplier of raw materials and enterprises with integrity!

Welcome to contact me by sending email to marketing@handebio.com


  • Previous:
  • Next: